ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Description

The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.

Conditions

Mycosis Fungoides, Non-Hodgkin's Lymphoma

Study Overview

Study Details

Study overview

The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.

Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Condition
Mycosis Fungoides
Intervention / Treatment

-

Contacts and Locations

Duarte

City of Hope, Duarte, California, United States, 91010

Palo Alto

Stanford University, School of Medicine, Palo Alto, California, United States, 94305

Iowa City

University of Iowa, Iowa City, Iowa, United States, 52242

Hackensack

Hackensack University Medical Center, Hackensack, New Jersey, United States, 07601

Pittsburgh

University of Pittsburg, Pittsburgh, Pennsylvania, United States, 15260

Dallas

University of Texas Southwestern, Dallas, Texas, United States, 75390

Salt Lake City

University of Utah Hospital, Salt Lake City, Utah, United States, 84132

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    to

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Stanford University,

    Youn H Kim, MD, PRINCIPAL_INVESTIGATOR, Stanford University

    Study Record Dates

    2027-03